# Biomarin Pharmaceutical Inc. (BMRN) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $3.22B |
| 2024 | $2.85B |
| 2023 | $2.42B |
| 2022 | $2.10B |
| 2021 | $1.85B |
| 2020 | $1.86B |
| 2019 | $1.70B |
| 2018 | $1.49B |
| 2017 | $1.31B |
| 2016 | $1.12B |
| 2015 | $890M |
| 2014 | $749M |
| 2013 | $548M |
| 2012 | $501M |
| 2011 | $441M |
| 2010 | $376M |
| 2009 | $325M |
| 2008 | $296M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $766M |
| 2025-09-30 | $776M |
| 2025-06-30 | $825M |
| 2025-03-31 | $745M |
| 2024-09-30 | $746M |
| 2024-06-30 | $712M |
| 2024-03-31 | $649M |
| 2023-09-30 | $581M |
| 2023-06-30 | $595M |
| 2023-03-31 | $596M |
| 2022-09-30 | $505M |
| 2022-06-30 | $534M |
| 2022-03-31 | $519M |
| 2021-09-30 | $409M |
| 2021-06-30 | $502M |
| 2021-03-31 | $486M |
| 2020-09-30 | $477M |
| 2020-06-30 | $429M |
| 2020-03-31 | $502M |
| 2019-09-30 | $461M |
| 2019-06-30 | $388M |
| 2019-03-31 | $401M |
| 2018-09-30 | $392M |
| 2018-06-30 | $373M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BMRN/revenue)